title: Early rheumatoid arthritis: does gender influence disease expression?
abstract: OBJECTIVE
  To investigate whether gender is an independent factor associated with disease expression in early rheumatoid arthritis (RA) patients.
  
  
  METHODS
  438 patients with early RA (disease duration less than one year) were studied. They all were patients with early RA who presented at the Rheumatology Clinic of the University Hospital of Ioannina during the period 1991-2000. All patients fulfilled the American College of Rheumatology criteria for RA. The demographic, clinical, laboratory, radiological and therapeutic characteristics of the disease at diagnosis, and at the last follow-up were analyzed according to gender.
  
  
  RESULTS
  We studied 312 women and 126 men with early RA. The female to male ratio was 2.5:1 and the mean age at diagnosis was 49.4 +/- 14.9 years for women and 55.3 +/-15.6 years for men (P < 0.0003). Women had a longer duration of follow-up (P < 0.0003). There were no differences between genders in the general symptoms or the simmetricity of joint involvement at at disease onset. However at disease onset women had a higher erythrocyte sedimentation rate (ESR) (> 30 mm/1st hour), although there were no significant differences between the two groups concerninig the rest of the clinical, laboratory and radiological findings. At the last follow-up women still had a higher ESR (>30 min/1st hour), but no significant differences were found between the two groups concerning the rest of the parameters investigated independently of the follow-up duration. Finally, women and men showed the same degree of radiological changes and functional ability and were treated similarly except for the more frequent use of hydroxychloroquine in women.
  
  
  CONCLUSIONS
  It seems that gender does not signficantly influence the expression of RA.
authors.affiliation: Division of Rheumatology, Department of Internal Medicine, Medical School, University of Ioannina, Ioannina, Greece.
authors.forename: P V
authors.initials: PV
authors.lastname: Voulgari
authors.forename: I A
authors.initials: IA
authors.lastname: Papadopoulos
authors.forename: Y
authors.initials: Y
authors.lastname: Alamanos
authors.forename: A
authors.initials: A
authors.lastname: Katsaraki
authors.forename: A A
authors.initials: AA
authors.lastname: Drosos
mesh_terms: D000293:Adolescent; D000328:Adult; D017668:Age of Onset; D000368:Aged; D000369:Aged, 80 and over; D018501:Antirheumatic Agents / Q000627:therapeutic use; D001172:Arthritis, Rheumatoid / Q000188:drug therapy / Q000453:epidemiology* / Q000503:physiopathology; D001175:Arthrography; D001799:Blood Sedimentation; D005260:Female; D006115:Greece / Q000453:epidemiology; D006801:Humans; D007596:Joints / Q000473:pathology / Q000503:physiopathology; D016015:Logistic Models; D008297:Male; D008875:Middle Aged; D012737:Sex Factors
chemical_list: D018501:Antirheumatic Agents